
Opinion|Videos|April 30, 2025
Regulatory Requirements and Credentialing for Pharmacy-Based Point-of-Care Testing
Author(s)Duane Jones, BS Pharm
A panelist discusses how obtaining a Clinical Laboratory Improvement Amendments (CLIA) waiver is an essential regulatory step for pharmacies to perform point-of-care testing, followed by credentialing with payers to receive reimbursement for these services.
Advertisement
Episodes in this series

Regulatory Framework and Credentialing
Main Discussion Topics:
- CLIA waiver requirements and regulatory compliance
- Pharmacist credentialing process with payers
- Documentation and protocol development importance
Key Points for Physicians:
- 48 states allow pharmacists to perform point-of-care testing
- Pharmacy testing requires CLIA waivers
- Pharmacies must establish protocols similar to those in medical practice settings
Notable Insights:
- Credentialing is a one-time process that creates ongoing opportunity
- Creating standardized documentation during initial implementation simplifies future onboarding
- State health departments often provide guidance and support for implementing testing programs
Clinical Significance:
Although regulatory and credentialing processes require an initial investment of time, they establish the foundation for pharmacy-based clinical services that can expand health care access points and create sustainable revenue streams through formalized medical billing pathways.
Advertisement
Related to this article

Detailed phase 3 data show retatrutide lowered body weight and A1C over 80 weeks for patients with diabetes and obesity.

In celebration of the organization’s recent convention, NCPA released its annual digest report for members, providing a detailed overview of independent community pharmacy.

Local collaborations can turn pharmacies into care-coordination hubs, but lasting results require trained teams, shared data, and sustainable payment.

In a rapidly evolving diabetes and obesity management landscape, Brian Smith, PharmD, discusses approaches that are helping patients maximize their outcomes on GLP-1 therapy.

A structured recommendation workflow at a community pharmacy was associated with more multivaccine patients than routine practice.

In part 2 of our pre-election series, detailing key health policies for pharmacists at this year’s midterms, a legal expert touches on MFN pricing, ACA subsidies, and more.

Pharmacists can improve cardiometabolic adherence by easing adverse effects, simplifying regimens, tackling costs, and synchronizing refills.
Advertisement
Advertisement
Trending on Drug Topics
1
Pharmacist Protocol Is Linked With More Same-Day Vaccine Coadministration
2
FAQ: Policies for Pharmacists to Track Heading into 2026 Midterms
3
Cost-Plus Pricing Reshapes Pharmacy, But Savings Are Not Guaranteed
4
Integrated Care and the Keys to Successful GLP-1 Therapy
5


